Therefore, CA-125 is mostly used to follow up the stage-wise progression of ovarian cancer in patients with established ovarian cancer5; other important protein biomarkers for ovarian cancers include leptin, prolactin, osteopontin, and insulin-like growth factor II (IGF-II).6 This evidence concerns the gene IGF2 and ovarian carcinoma.